Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Staff cuts are undermining federal research on how to make health care better

0 Mins
AHRQ has been gutted by staff cuts that leave it unable to fund research designed to improve care.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago